6-(1-Benzyl-1H-pyrrol-2-yl)-2,4-dioxo-5-hexenoic Acids as Dual Inhibitors of Recombinant HIV-1 Integrase and Ribonuclease H, Synthesized by a Parallel Synthesis Approach
Integrase inhibitor
DOI:
10.1021/jm401040b
Publication Date:
2013-10-14T17:19:16Z
AUTHORS (14)
ABSTRACT
The increasing efficiency of HAART has helped to transform HIV/AIDS into a chronic disease. Still, resistance and drug–drug interactions warrant the development new anti-HIV agents. We previously discovered hit 6, active against HIV-1 replication targeting RNase H in vitro. Because its diketo-acid moiety, we speculated that this chemotype could serve develop dual inhibitors both integrase. Here, describe series 1-benzyl-pyrrolyl diketohexenoic derivatives, 7a–y 8a–y, synthesized following parallel solution-phase approach. Those 50 analogues have been tested on recombinant enzymes (RNase integrase) cell-based assays. Approximately half (22) exibited inhibition HIV replication. Compounds 7b, 7u, 8g were most activity reverse-transcriptase, with IC50 values 3, 2.5 μM, respectively. Compound was also potent integrase inhibitor an value 26 nM.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (33)
CITATIONS (52)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....